Yue Guo

Yue Guo

Auto-generated profile, based on publicly available information

Yue Guo

The Chinese University of Hong Kong, Hong Kong Special Administrative Region Department of Surgery, Faculty of Medicine, 999077

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2016 in The AAPS Journal
Verified
Journal Article
Open access
PDF file
BHBo Hong
Bo Hong
Zheng-Yuan SuZheng-Yuan Su
Zheng-Yuan Su
CZChengyue Zhang
Chengyue Zhang
YYYuqing Yang
Yuqing Yang
YGYue Guo
Yue Guo
AKAh-Ng Kong
Ah-Ng Kong
Nuclear factor erythroid-2 related factor 2 (Nrf2) is a crucial transcription factor that regulates the expression of defensive antioxidants and detoxification enzymes in cells. In a previous study, we showed that expression of the Nrf2 gene is regulated by an epigenetic modification. Rauvolfia verticillata, a traditional Chinese herbal medicine widely used in China, possesses anticancer and antioxidant effects. In this study, we investigated how Nrf2 is epigenetically regulated by reserpine, the main active component in R. verticillata, in mouse skin epidermal JB6 P+ cells. Reserpine induced ARE (antioxidant response element)-luciferase activity in HepG2-C8 cells. Accordingly, in JB6 P+ cells, it upregulated the mRNA and protein levels of Nrf2 and its downstream target genes heme oxygenase-1 (HO-1) and quinone oxidoreductase 1 (NQO1), while it only increased the protein level of UDP-glucuronosyltransferase 1A1 (UGT1A1). Furthermore, reserpine decreased the TPA (12-O-tetradecanoylphorbol-13-acetate)-induced colony formation of JB6 cells in a dose-dependent manner. DNA sequencing and methylated DNA immunoprecipitation further demonstrated the demethylation effect of reserpine on the first 15 CpGs of the Nrf2 promoter in JB6 P+ cells. Reserpine also reduced the mRNA and protein expression of DNMT1 (DNA methyltransferase 1), DNMT3a (DNA methyltransferases 3a), and DNMT3b (DNA methyltransferases 3b). Moreover, reserpine induced Nrf2 expression via an epigenetic pathway in skin epidermal JB6 P+ cells, enhancing the protective antioxidant activity and decreasing TPA-induced cell transformation. These results suggest that reserpine exhibits a cancer preventive effect by reactivating Nrf2 and inducing the expression of target genes involved in cellular protection, potentially providing new insight into the chemoprevention of skin cancer using reserpine.

10 October 2025 in Science Advances
Verified
Journal Article
Open access
YGYue Guo
Yue Guo
MXMingjing Xu
Mingjing Xu
HXHua Xue
Hua Xue
XDXiaofan DING
Xiaofan DING
AWAlissa M Wong
Alissa M Wong
NWNathalie Wong
Nathalie Wong
Although genome sequencings have recognized many cancer-associated genes in hepatocellular carcinoma (HCC), distinguishing their functional effect remains challenging. Leveraging on a genome-wide CRISPR knockout (KO) screening, we uncovered spliceosome factors as major survival essential genes in HCC and up-regulations of ferroptosis suppressors [particularly glutamate-cysteine ligase catalytic subunit (GCLC)] in lenvatinib resistance. Our KO screen in patient-derived HCC organoid showed splicing factor 3b subunit 4 (SF3B4) to be top-ranked, conferring prosurvival signal in HCC organoid and driving tumorigenic potentials in both hepatic progenitor organoids and hydrodynamic tail vein injection HCC murine model. The combined RNA immunoprecipitation sequencing, long-read isoform sequencing, and transcriptome revealed characteristic splicing landscape regulated by SF3B4 and identified T-box transcription factor 3 (TBX3) variant TBX3+2a as a potent downstream effector. Our findings highlighted vital roles of SF3B4 in HCC cell survival and tumor progression, and the phenomenon of ferroptosis resistance in patients unresponsive to first-line agent lenvatinib.

9 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SLStephen Li
Stephen Li
YDYujuan Dong
Yujuan Dong
JLJiaxun Liu
Jiaxun Liu
SLShanglin Li
Shanglin Li
DPDandan Pu
Dandan Pu
JWJason W. H. Wong
Jason W. H. Wong
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal form of liver cancer marked by high rates of tumor recurrence, posing substantial challenges to primary treatment options such as surgical resection and liver transplantation. Immunotherapy, which leverages T-cell-mediated recognition of tumor-specific antigens, has emerged as a promising alternative therapeutic strategy. While proteogenomics and ribosome profiling data across cancer types have provided growing evidence of active translation in non-canonical open reading frames (ncORFs), antigens derived from HCC-associated ncORFs remain largely unexplored. By integrating long-read and short-read RNA sequencing data with mass spectrometry, we have successfully identified twelve non-canonical peptides arising from cryptic translation of ncORFs. ELISpot assays confirmed cytokine release triggered by non-canonical peptides originating from distinct genomic loci. Subsequent RNA level analysis revealed four peptides with strong evidence of enriched expression in tumorigenesis. In-depth bioinformatics predictions indicate that these four peptides possess significant binding affinity for Major Histocompatibility Complex and T-Cell Receptor, with p2 emerging as the most promising candidate. Analysis using public datasets and experimental validation further highlighted the role of ribosome subunit recruitment and N6-Methyladenosine (m 6 A) modifications in enhancing translation initiation for tumor-enriched antigens. By addressing the existing shortage of knowledge in the HCC ncORF translation, this study identifies promising antigenic candidates for HCC immunotherapy, offering new avenues for effective treatment strategies and improved patient outcomes.

13 August 2026 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
SLStephen Li
Stephen Li
YDYujuan Dong
Yujuan Dong
JLJiaxun Liu
Jiaxun Liu
SLShanglin Li
Shanglin Li
DPDandan Pu
Dandan Pu
JWJason W. H. Wong
Jason W. H. Wong
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal form of liver cancer marked by high rates of tumor recurrence, posing substantial challenges to primary treatment options such as surgical resection and liver transplantation. Immunotherapy, which leverages T-cell-mediated recognition of tumor-specific antigens, has emerged as a promising alternative therapeutic strategy. While proteogenomics and ribosome profiling data across cancer types have provided growing evidence of active translation in non-canonical open reading frames (ncORFs), antigens derived from HCC-associated ncORFs remain largely unexplored. By integrating long-read and short-read RNA sequencing data with mass spectrometry, we have successfully identified twelve non-canonical peptides arising from cryptic translation of ncORFs. Enzyme-linked immunosorbent spot (ELISpot) assays confirmed cytokine release triggered by non-canonical peptides originating from distinct genomic loci. Subsequent RNA level analysis revealed four peptides with strong evidence of enriched expression in tumorigenesis. In-depth bioinformatics predictions indicate that these four peptides possess significant binding affinity for Major Histocompatibility Complex and T-Cell Receptor, with p2 emerging as the most promising candidate. Analysis using public datasets and experimental validation further highlighted the role of ribosome subunit recruitment and N6-Methyladenosine (m6A) modifications in enhancing translation initiation for tumor-enriched antigens. By addressing the existing shortage of knowledge in the HCC ncORF translation, this study identifies promising antigenic candidates for HCC immunotherapy, offering new avenues for effective treatment strategies and improved patient outcomes.